
Children's ADHD risk linked to mothers' use of common OTC pain reliever
Children could face a higher risk of developing attention-deficit/hyperactivity disorder (ADHD) if their mothers took acetaminophen — a common pain reliever and fever reducer — during pregnancy, researchers have found.
The study, which has sparked new discussions about the controversial topic, was recently published in the journal Nature Mental Health.
"Compared with no exposure, detection of acetaminophen in maternal blood during pregnancy was linked with three times the likelihood of the child developing ADHD," lead author Brennan Baker, a researcher at Seattle Children's Research Institute, told Fox News Digital.
To gather the data, researchers took blood samples from 307 Black women during their second trimester of pregnancy, then tested for markers of the fever-reducing medication.
They also sampled the mothers' placentas after delivery to look for signs of increased inflammation in those exposed to acetaminophen.
(Previous studies have linked elevated inflammatory and immune responses during pregnancy with adverse neurodevelopment in children, Baker noted.)
Researchers then followed up with the children at 8 to 10 years of age to determine how many had been diagnosed with ADHD, then determined whether prenatal exposure to acetaminophen was linked with a higher likelihood of the disorder.
The researchers also found DNA changes related to immune system pathways in the placentas that were exposed to acetaminophen, which was linked to a higher chance of children developing ADHD.
"What this study does well is push us closer to understanding modifiable prenatal risk factors."
"This indicates that disruptions to the immune system could be a mechanism linking this exposure with child neurodevelopment," Baker said.
Dr. Ryan Sultan, an attending physician at NewYork-Presbyterian Hospital and director of the Mental Health Informatics Lab at Columbia University Irving Medical Center, said the study's findings are both "important and concerning."
"What this study does well is push us closer to understanding modifiable prenatal risk factors," Sultan, who was not involved in the research, told Fox News Digital.
While the study adds to the growing consensus that acetaminophen is not risk-free, that doesn't mean pregnant women can't take Tylenol or other medications containing acetaminophen, experts told Fox News Digital.
"When possible, it should be used sparingly and only when medically necessary during pregnancy," Sultan advised.
There is a conflicting body of research on the use of acetaminophen during pregnancy and the risk of adverse neurodevelopment.
For example, a recent study of nearly 2.5 million Swedish children last year found no increased risk of autism, ADHD or intellectual disability among siblings who were exposed to the pain medication before birth.
A nationwide study in Taiwan, however, found that the use of acetaminophen in pregnancy increased the development of ADHD in offspring, regardless of whether the mothers had mental health disorders.
Many prior studies have relied on mothers' self-reporting – which underestimates use, as many people take acetaminophen without knowing it, according to Baker.
Sultan cautioned that the study has some limitations.
Its sample size was small, the population was limited to Black mothers in the South, and exposure to acetaminophen was measured only at a single point in time, he noted.
Another major limitation is the study design, as it cannot prove that acetaminophen use causes ADHD.
"We can never be 100% sure that an association is causal in an observational study like this, as there can always be unknown confounding factors," Baker told Fox News Digital.
"We tried to control for as many factors as possible, including family history of mental health conditions, maternal use of antibiotics, maternal use of other drugs used for pain/fever, socioeconomic status of the family, and prenatal tobacco and alcohol exposure," he added.
While the researchers may have identified a possible risk for ADHD, the mental health condition is a "complex, multifactorial deficit in executive functioning" that can manifest in a variety of ways, according to Dr. Lama Bazzi, a psychiatrist in private practice in New York City.
"We can never be 100% sure that an association is causal in an observational study like this."
There are approximately six million pregnancies every year and 80% of women take at least one medication for a health problem diagnosed before or during pregnancy, according to the U.S. Food & Drug Administration.
The majority of women take acetaminophen at some point during pregnancy, with more use among those with anxiety and depression, according to past research.
For more Health articles, visit www.foxnews.com/health
ADHD is one of the most common mental health conditions during childhood, according to the American Psychiatric Association.
The study was funded in part by the National Institutes of Health. Fox News Digital reached out to manufacturers of medications containing acetaminophen for comment.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
2 hours ago
- Business Wire
Party With a Purpose: Republic Bank hosts fifth annual Juneteenth Event to improve health outcomes in West Louisville
LOUISVILLE, Ky.--(BUSINESS WIRE)--Today, Republic Bank & Trust Company ('Republic' or 'the Bank') hosted the fifth annual Juneteenth Event at the Republic Bank Foundation YMCA. Republic partnered with Kentucky African Americans Against Cancer (KAAAC) and other community organizations to offer free screenings and educational resources to improve the health of West Louisville residents. 'Republic Bank welcomes the opportunity to host this important community event each year in celebration of Juneteenth,' Republic Bank President and CEO Logan Pichel said. 'Republic Bank welcomes the opportunity to host this important community event each year in celebration of Juneteenth,' Republic Bank President and CEO Logan Pichel said. 'We are committed to investing in West Louisville, improving the quality of life and enabling the communities we serve to thrive. Not only are we able to help Louisvillians access life-saving health screenings and resources, but today's event offered everyone an opportunity to celebrate with the community.' According to the American Cancer Society, one in eight men will be diagnosed with prostate cancer in their lifetime, with the risk for Black men being significantly higher. Moreover, a recent National Institutes of Health (NIH) study concluded that Black men have a higher prevalence of prostate cancer because of lower prostate exam screening rates. Additionally, the average dental screening costs about $130, and according to the Kentucky Oral Health Coalition, poor oral health is linked to a number of health conditions including heart disease, diabetes, high blood pressure, stroke and Alzheimer's disease. Further, the Centers for Disease Control and Prevention (CDC) reported that the highest prevalence of fatal oral cancers is among Black Americans, and they are three times more likely to have untreated cavities. In addition to free prostate screenings provided by KAAAC, KARE Mobile offered complementary dental screenings for all attendees. Attendees also enjoyed activities, food and vendors operated by Black- and women-owned businesses. 'We're thrilled to celebrate Juneteenth in West Louisville for the fifth year in a row,' Republic Bank Vice President, Inclusion and Diversity Ashley Duncan said. 'We're grateful for our community partners like KAAAC and Kare Mobile that are helping us reach underserved communities and save lives.' About Republic Bank Republic Bancorp, Inc. (the 'Company') is the parent company of Republic Bank & Trust Company (the 'Bank'). The Bank currently has 47 banking centers in communities within five metropolitan statistical areas ('MSAs') across five states: 22 banking centers located within the Louisville MSA in Louisville, Prospect, Shelbyville, and Shepherdsville in Kentucky, and Floyds Knobs, Jeffersonville, and New Albany in Indiana; six banking centers within the Lexington MSA in Georgetown and Lexington in Kentucky; eight banking centers within the Cincinnati MSA in Cincinnati and West Chester in Ohio, and Bellevue, Covington, Crestview Hills, and Florence in Kentucky; seven banking centers within the Tampa MSA in Largo, New Port Richey, St. Petersburg, Seminole, and Tampa in Florida; and four banking centers within the Nashville MSA in Franklin, Murfreesboro, Nashville and Spring Hill, Tennessee. In addition, Republic Bank Finance has one loan production office in St. Louis, Missouri. The Bank offers online banking at The Company is headquartered in Louisville, Kentucky, and as of March 31, 2025, had approximately $7.1 billion in total assets. The Company's Class A Common Stock is listed under the symbol 'RBCAA' on the NASDAQ Global Select Market.
Yahoo
4 hours ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration
Yahoo
5 hours ago
- Yahoo
Is Learned Helplessness Preventing You from Overcoming Trauma? A Therapist Explains
Learned helplessness. I'd heard the term before, but conflated it with weaponized incompetence, a phenomenon where someone (usually the male partner in a hetero relationship) exerts little or no effort in a task to avoid completing it and/or not being asked to do it again. (Think: the husband who 'doesn't know where the spoons go.') The more I read about learned helplessness, the more I realized these two concepts are the same. Learned helplessness is actually a body's response to trauma—not your toxic masculinity scheming to get out of dishwasher duty. So I spoke with a licensed social worker with over a decade of experience supporting individuals with PTSD, anxiety, depression and other conditions, to better understand what learned helplessness actually is and how to move past it to heal. Lesley Broff is a licensed social worker who graduated from The University of Pittsburgh with her Masters degree in Social Work. She has over 10 years of experience working in community mental health settings with adults with severe mental health diagnoses, adults with disabilities, and children, adults and families with conditions including anxiety, depression, PTSD, ADHD and Autism. Learned helplessness, Broff explains, 'stems from repeated experiences of perceived failure or adversity where nothing [a person has] tried seemed to make a difference.' Essentially, the social worker expands, it's when a person comes to believe they have no control over a situation, even when change is possible: 'In everyday life, it presents in things like giving up easily, not speaking up in challenging situations or assuming efforts won't lead to success—like a student who stops studying because past attempts didn't help, or someone who stays silent in meetings because they believe their voice won't matter.' Learned helplessness can sound like this: Trauma can teach the nervous system to give up. 'Trauma—especially the kind that's prolonged or feels inescapable—can literally rewire the nervous system to believe safety isn't possible,' Broff explains. 'Over time, disengagement or submission becomes a survival strategy.' For survivors of childhood abuse, domestic violence or chronic injustice, learned helplessness can settle in early. You try to fight back. You try to speak up. But when nothing changes—or worse, things escalate—your brain associates effort with futility. So, to survive, you must submit or disengage. 'Learned helplessness is the nervous system's way of saying, 'Survive now, heal later,'' says Broff. While staying small, quiet and helpless may be adaptive in the moment, 'problems arise when this protective strategy continues even after the threat is gone, making it harder to pursue change, growth or connection.' Everyone has rough weeks (or months). But learned helplessness is a pattern. 'If you're noticing a chronic belief that nothing you do will make a difference, across many parts of life—that's a signal,' says Broff. You may find yourself withdrawing from support, brushing off opportunities, or assuming the worst before you even try. It's not a failure of character—it's a conditioned response. Unlearning helplessness isn't about flipping a magical confidence switch. 'In therapy, we work on both thoughts and behaviors,' says Broff. 'We examine the beliefs that keep someone stuck, and we gently test them with small, manageable actions.' One of the most powerful disruptors to learned helplessness, she stresses, is also connection. 'Safe relationships help mirror back your capacity and your value,' says Broff. That could be a therapist, a friend, a support group—or even a familiar object that offers a sense of being held when people don't feel accessible. Broff mentions Percy the 3 Lb. Hug Bear , a sensory bear, which can offer grounding for those whose bodies still feel on high alert. Know this: it's not your fault. 'This way of thinking doesn't come from who you are—it comes from your nervous system, which was trained by your past to expect threats,' says Broff. 'But your past doesn't dictate your future.' Calling All People Pleasers: Here's Everything You Need to Know About Fawn Trauma Response, According to a Therapist